A61M 15/0098
Activated by exhalation
Official title: {Activated by exhalation}
A61M15/0098 (Activated by exhalation) appears on 125 US grants and 200 published applications in this corpus.
Search patents in A61M- Granted patents
- 125
- Published applications
- 200
- Assignees
- 54
- Inventors
- 135
- Latest grant
- 1 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 2 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 3 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 1 |
| 2003 | 1 | 1 |
| 2004 | 2 | 5 |
| 2005 | 0 | 4 |
| 2006 | 0 | 8 |
| 2007 | 0 | 3 |
| 2008 | 2 | 6 |
| 2009 | 2 | 7 |
| 2010 | 4 | 9 |
| 2011 | 2 | 11 |
| 2012 | 5 | 4 |
| 2013 | 9 | 6 |
| 2014 | 6 | 13 |
| 2015 | 13 | 14 |
| 2016 | 5 | 25 |
| 2017 | 4 | 11 |
| 2018 | 9 | 6 |
| 2019 | 8 | 13 |
| 2020 | 12 | 10 |
| 2021 | 5 | 12 |
| 2022 | 8 | 8 |
| 2023 | 7 | 6 |
| 2024 | 5 | 2 |
| 2025 | 2 | 11 |
| 2026 | 2 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Positive exhalation pressure device1 Sep 2026US 12,721,961 B2Solopep Limited
- Nasal administration5 May 2026US 12,616,806 B2OptiNose AS
- Nasal delivery devices23 Dec 2025US 12,502,497 B2OptiNose AS
- Drug delivery devices and methods for administering substances to a body cavity by heterogenous aerosolization for treatment of binge-eating disorders and/or obesity9 Dec 2025US 12,491,325 B2AptarGroup, Inc.
- Methods and apparatus for producing herbal vapor29 Oct 2024US 12,128,175 B2Target Group Inc.
- Nasal administration20 Aug 2026US 2026/0241121 A1OptiNose AS
- Drug delivery devices and methods for administering substances to a body cavity by heterogenous aerosolization for treatment of binge-eating disorders and/or obesity14 May 2026US 2026/0131089 A1AptarGroup, Inc.
- Exhalation-Enhanced, Nasal-Spray Apparatus for Delivering Aerosolized Liquid Substance19 Mar 2026US 2026/0077142 A1
- Nasal delivery devices12 Mar 2026US 2026/0069799 A1OptiNose AS
- Nasal administration6 Nov 2025US 2025/0339632 A1OptiNose AS
Most cited
By later US patents